Drugs · Entity Annotation Prototype (beta)

6articles mentioning drugs

24drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: SGLT-2is ×

SGLT-2is

This drug is selected. Its supporting articles are shown below.

SGLT-2is6

Articles mentioning SGLT-2is

6 articles · page 1 of 1

Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study

bmjdrc · full text · 2026-03-18 · 9 matching annotations

95.7%

DPP-4is GLP-1 RAs GLP-1 RA SGLT-2is DPP-4i

…CI −0.53 to 0.86 events per 1000 person-years) or compared with DPP-4is (HR 0.94; 95% CI 0.71 to 1.24, rate difference −0.18; 95% CI −0…

Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research Datalink

openhrt · abstract · 2025-08-26 · 5 matching annotations

94.0%

metformin SGLT-2is DPP-4is DPP-4i DPP4-i SGLT-2i type 2 diabetes

…T-2is versus DPP-4is in type 2 diabetes and (2) SGLT-2is versus metformin monotherapy among subjects with a diabetes duration of <5 years…

Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study

bmjdrc · abstract · 2026-03-18 · 4 matching annotations

93.0%

GLP-1 RAs DPP-4is SGLT-2is dipeptidyl peptidase-4 inhibitors sodium-glucose cotransporter-2 inhibitors glucagon-like peptide 1 receptor agonists

…g reports of suicidal ideation and behaviors in patients taking GLP-1 RAs. This study assessed a potential association with intentional s…

Overcoming therapeutic inertia in primary care: a multisite quality initiative to increase guideline-based prescribing for patients with diabetes

bmjqir · abstract · 2025-10-22 · 3 matching annotations

93.4%

Insulin SGLT-2i SGLT-2is GLP-1RA GLP-1RAs sodium-glucose cotransporter 2 inhibitors sulfonylurea

…d significantly after intervention (−2.0% per quarter; p=0.02). Insulin prescribing rates did not change throughout the study period. T…

Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care

bmjdrc · full text · 2025-10-29 · 2 matching annotations

81.0%

semaglutide metformin

…he results of the ongoing SEPRA trial, we found that injectable semaglutide was superior to SoC with 30% more patients achieving A1C <7% at…

Assessment of regional variation in the management of heart failure with a preserved ejection fraction between the Russian Federation and the European Union: the results of the international survey

bmjopen · abstract · 2025-08-13 · 1 matching annotations

89.4%

SGLT2is SGLT-2is sodium-glucose co-transporter type 2 inhibitors ACE inhibitors HFpEF heart failure

…ns prioritised sodium-glucose co-transporter type 2 inhibitors (SGLT2is) (mean rank: RF: 2.6 (IQR: 2.3–3) vs EU: 2.3 (IQR: 2.2–2.5)), f…

Browse drugs

SGLT-2is

Articles mentioning SGLT-2is

Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study

Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research Datalink

Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study

Overcoming therapeutic inertia in primary care: a multisite quality initiative to increase guideline-based prescribing for patients with diabetes

Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care

Assessment of regional variation in the management of heart failure with a preserved ejection fraction between the Russian Federation and the European Union: the results of the international survey